News Snapshot:
Agency February 18, 2021 Health workers prepare to start vaccination against the coronavirus disease (COVID-19) in Kathmandu, Nepal January 27, 2021. REUTERS/Navesh Chitrakar KATHMANDU (Reuters) – Nepal approved on Thursday the emergency use of a COVID-19 vaccine developed by an affiliate of China’s Sinopharm , a government official said, the second vaccine cleared after AstraZeneca’s product. The move paves the way for China to donate 500,000 doses of the Sinopharm vaccine to the Himalayan nation, which last month received one million doses of the AstraZeneca vaccine free of charge from its other big neighbour India. Nepal will also buy the...
